Dr. Dagmar Doby, MBA
Global Director Access Reimbursement And Pricing Oncology @ Eli Lilly and Company
About Dr. Dagmar Doby, MBA
Dr. Dagmar Doby, MBA, serves as the Global Director of Access Reimbursement and Pricing Oncology at Eli Lilly and Company, a position she has held since 2017. With a medical degree from Medizinische Universität Wien and extensive experience in pricing and reimbursement roles, she has contributed significantly to the field of oncology over her tenure at the company.